Amgen Absorbs Horizon, Pitches Plans For New Rare Disease Growth Engine

Full-Year 2023 Guidance Raised By At Least $1bn

 
• By Mandy Jackson
  
Mountain road. Landscape with green field, sunny sky with clouds and beautiful asphalt road in the morning. Scenic background.
Horizon brings Amgen a multi-drug rare disease portfolio • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business